Chimerix (NASDAQ: CMRX) provided an update on the company's R&D programs, including the addition of a potential new product candidate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE